Two hairstylists in Springfield, Missouri, tested positive for COVID-19 in late May. Together they had seen 140 customers since the salon reopened. They may have been contagious the whole time. But instead of detecting a cluster of new cases, local public-health had 46 salon customers tested for the virus, not one was positive. The reason is attributed to the universal wearing of masks by both stylists and customers. The science is beginning to back up what many have known for a while, that masks are our most powerful weapon in the fight against COVID-19.
There is a growing body of evidence that wearing face masks can slow the transmission of coronavirus and can potentially save many lives. One recent study published in the Proceedings of the Royal Society in the UK found that even adopting face masks 120 days after the beginning of an outbreak of COVID 100% wearing of masks by the public could completely stop the occurrence of further waves of coronavirus. This study and many others are showing that, when facemasks are used by the public all the time (not just from when symptoms first appear), the effective reproduction number, Re, can be decreased below 1, leading to the mitigation of epidemic spread. In other words, even at this late hour, we can stop the spread of this disease by the widespread adoption of wearing masks even before symptoms begin to show.
These analyses may explain why some countries, where adoption of facemask use by the public is around 100%, have experienced significantly lower rates of COVID-19 spread and associated deaths. current studies are showing that facemask use by the public, when used in combination with physical distancing or periods of lock-down, may provide an acceptable way of managing the COVID- 19 pandemic and re-opening economic activity. These results are especially relevant to the developing world, where large numbers of people are resource-poor, but fabrication of home-made, effective facemasks is possible. In Taiwan, Singapore, South Korea, Vietnam, and many other Asian countries they have managed to effectively reduce the number of cases and deaths with almost universal mask-wearing.
Stutt ROJH, Retkute R, Bradley M, Gilligan CA, Colvin J. 2020 A modeling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic. Proc. R. Soc. A 476: 20200376.
It is much easier in Asian countries to get the public to wear masks because with 322 pandemics in Asia in the last 2000 years, they have a long history of doing so. The custom of wearing masks in Asia to ward off diseases has its origins in ancient Chinese medicine. In ancient Chinese culture, masks were thought of as being a form of communication between mortal men and the immortal gods. They were thought to bring blessings, drive away evil spirits, ward off diseases, and protect the owner from various disasters. In the 13th century, Italian explorer Marco Polo recounted how servants in the Yuan dynasty court were required to cover their noses and mouths with a cloth of silk and gold thread when serving food to the emperor. In late 1910, the legendary Malaysian-Chinese doctor Wu Lien-teh was serving as China’s chief medical officer when an epidemic broke out in Northeast China. Wu went deep into the affected areas to lead prevention and control work and soon identified the epidemic as a form of pneumonic plague spread by droplets in the air. In addition to proposing now-familiar-sounding measures — including quarantining patients and cordoning off many cities — Wu also designed and invented a cheap sanitary face mask that promised some protection from the disease. https://www.sixthtone.com/news/1005177/a-brief-history-of-face-masks-in-china
In the US the public and even the public health authorities resisted the idea of the ordinary people wearing masks. Recently DR. Anthony Fauci admitted that public health officials downplayed the efficacy of masks to ensure they would be available for health care workers. The World Health Organization and the CDC both recommended that people not wear masks. Our own Surgeon general Jerome Adams said” they are not effective in preventing the general public from catching coronavirus, but if healthcare providers can’t get them to care for sick patients it puts them and our communities at risk”. (February 29th, 2020) Months later now, Dr. Anthony Fauci assured people that “masks do work and act as a protection for both healthy people and to prevent infected individuals from spreading the infection to others”. Since then the use of face coverings has become mandatory in most places including businesses, especially for employees.
Confusing recommendations continue
The public health recommendations in the US continue to be confusing. One recommendation says people should wear masks when they leave their homes. Another recommends people wear a mask if they cannot properly social distance. In Denver, face masks are not required when exercising outside. But the U.S. Centers for Disease Control and Prevention still recommends people wear cloth face coverings when out in public, especially in places where it’s hard to stay at least 6 feet away from others.
If it’s difficult to breathe through a mask when running or doing other strenuous physical activity, find uncrowded trails or times to exercise when you won’t encounter others, says Mark Cameron, an infectious disease expert at Case Western Reserve University.
Now the CDC is planning to update its recommendation on face masks. Researchers have been conducting a scientific review about the use of masks during the pandemic.
Scientists wanted to study to see if the masks protect people from contracting COVID-19 and not just preventing them from spreading it.
The new guidance is expected to be released soon, better late than never.
A key message from these latest studies to aid the widespread adoption of facemasks would be: ‘my mask protects you, your mask protects me’.
1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. 2020 The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544. (doi:10.1038/s41564-020-0695-z)
2. Chetty R, Stepner M, Abraham S, Lin S, Scuderi B, Turner N, Bergeron A, Cutler D. 2016 The association between income and life expectancy in the United States, 2001–2014. JAMA 315, 1750. (doi:10.1001/jama.2016.4226)
3. van Doremalen N et al. 2020 Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382, 1564–1567. (doi:10.1056/NEJMc2004973)
4. World Health Organization. 2020 Coronavirus disease 2019 (COVID-19). WHO situation report -73. See https://www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200402- sitrep- 73- covid- 19.pdf.
5. Liu X, Zhang S. 2020 COVID-19: face masks and human-to-human transmission. Influenza Other Respir Viruses. See http://doi.wiley.com/10.1111/irv.12740.
6. Noakes CJ, Beggs CB, Sleigh PA, Kerr KG. 2006 Modelling the transmission of airborne infections in enclosed spaces. Epidemiol. Infect. 134, 1082–1091. (doi:10.1017/ S0950268806005875)
7. Noakes CJ, Sleigh PA. 2009 Mathematical models for assessing the role of airflow on the risk of airborne infection in hospital wards. J. R Soc. Interface. 6, S791–S800. (doi:10.1098/rsif.2009.0305.focus)
8. Ferguson NM et al. 2020 Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. See https://www.imperial.ac.uk/
royalsocietypublishing.org/journal/rspa Proc. R. Soc. A 476: 20200376 ………………………………………………….
media/imperial- college/medicine/sph/ide/gida- fellowships/Imperial- College- COVID19-
9. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. 2020 Projecting the transmission
dynamics of SARS-CoV-2 through the postpandemic period. Science 368, 860–868.
10. Kucharski AJ et al. 2020 Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect. Dis. 20, 553–558. (doi:10.1016/S1473-3099
11. Li R et al. 2020 Substantial undocumented infection facilitates the rapid dissemination of novel
coronavirus (SARS-CoV2). Science 368, 489–493.
12. Matrajt L, Leung T. 2020 Evaluating the effectiveness of social distancing interventions
to delay or flatten the epidemic curve of coronavirus disease. Emerg. Infect. Dis. 26.
13. Prem K et al. 2020 The effect of control strategies to reduce social mixing on outcomes of the
COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health 5, e261–e270.
14. Wu JT, Leung K, Leung GM. 2020 Nowcasting and forecasting the potential domestic and
international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling
study. Lancet 395, 689–697. (doi:10.1016/S0140-6736(20)30260-9)
15. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ, Lipsitch M,
Leung GM. 2020 Estimating clinical severity of COVID-19 from the transmission dynamics in
Wuhan, China. Nat. Med. 26, 506–510. (doi:10.1038/s41591-020-0822-7)
16. Jefferson T et al. 2011 Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Acute Respiratory Infections Group. Cochrane Database Syst. Rev. 7,
17. Zhang L et al. 2013 Protection by face masks against influenza A(H1N1)pdm09 virus on trans-
Pacific passenger aircraft, 2009. Emerg. Infect. Dis. 19, 1403–1410. (doi:10.3201/eid1909.121765).
18. Peak CM, Childs LM, Grad YH, Buckee CO. 2017 Comparing nonpharmaceutical interventions for containing emerging epidemics. Proc. Natl Acad. Sci. USA 114, 4023–4028.
19. Anderson RM, May RM. 2010 Infectious diseases of humans: dynamics and control. Oxford, UK:
Oxford University Press.
20. Bjørnstad ON, Shea K, Krzywinski M, Altman N. 2020 Modeling infectious epidemics. Nat.
Methods 17, 455–456. (doi:10.1038/s41592-020-0822-z)
21. Smith SMS, Sonego S, Wallen GR, Waterer G, Cheng AC, Thompson P. 2015 Use of non-
pharmaceutical interventions to reduce the transmission of influenza in adults: a systematic
review: NPI efficacy in influenza. Respirology 20, 896–903. (doi:10.1111/resp.12541)
22. Yan J, Guha S, Hariharan P, Myers M. 2019 Modeling the effectiveness of respiratory protective devices in reducing influenza outbreak: modeling the effectiveness of respiratory
protective devices. Risk Anal. 39, 647–661. (doi:10.1111/risa.13181)
23. Suess T et al. 2012 The role of facemasks and hand hygiene in the prevention of influenza
transmission in households: results from a cluster randomised trial; Berlin, Germany,
2009–2011. BMC Infect. Dis. 12, 26. (doi:10.1186/1471-2334-12-26)
24. Centers for Disease Control and Prevention. 2020 Use of cloth face coverings to help slow the
spread of COVID-19. See https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-
sick/diy- cloth- face- coverings.html.
25. van der Sande M, Teunis P, Sabel R. 2008 Professional and home-made face masks reduce
exposure to respiratory infections among the general population. PLoS ONE 3, e2618.
26. Long Y et al. 2020 Effectiveness of N95 respirators versus surgical masks against influenza:
a systematic review and meta-analysis. J. Evid Based Med. (doi:10.1111/jebm.12381)
27. Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE. 2016 Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. Can. Med. Assoc. J. 188, 567–574.
28. European Centre for Disease Prevention and Control. 2020 Using face masks in the community:
reducing COVID-19 transmission from potentially asymptomatic or pre-symptomatic people through the use of face masks. Stockholm, Sweden: ECDC. See https://www.ecdc.europa.eu/sites/ default/files/documents/COVID- 19- use- face- masks- community.pdf.
royalsocietypublishing.org/journal/rspa Proc. R. Soc. A 476: 20200376 ………………………………………………….
29. Ferretti L, Wymant C, Kendall M, Zhao L, Nurtay A, Abeler-Dörner L, Parker M, Bonsall D, Fraser C. 2020 Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science 368, eabb6936. (doi:10.1126/science.abb6936)
30. Flaxman S et al. 2020 Report 13: estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries. See https://www. imperial.ac.uk/media/imperial- college/medicine/sph/ide/gida- fellowships/Imperial- College- COVID19- Europe- estimates- and- NPI- impact- 30- 03- 2020.pdf.
31. Hellewell J et al. 2020 Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 8, e488–e496. (doi:10.1016/S2214-109X(20)30074-7)
32. Jombart T et al. 2020 Inferring the number of COVID-19 cases from recently reported deaths. Wellcome Open Res. 5, 78. (doi:10.12688/wellcomeopenres.15786.1)
33. Peak CM et al. 2020 Comparative impact of individual quarantine vs. active monitoring of contacts for the mitigation of COVID-19: a modelling study. (https://www.medrxiv.org/ content/10.1101/2020.03.05.20031088v2)
34. Pellis L et al. 2020 Challenges in control of Covid-19: short doubling time and long delay to effect of interventions. (https://arxiv.org/abs/2004.00117v1)
35. Plank MJ, Binny RN, Hendy SC, Lustig A, James A, Steyn N. 2020 A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand. (https://www. medrxiv.org/content/10.1101/2020.04.08.20058743v1)
36. Riou J, Althaus CL. 2020 Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance 25, 2000058. (doi:10.2807/1560-7917.ES.2020.25.4.2000058)
37. Zhuang Z et al. 2020 Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020. Int. J. Infect. Dis. 95, 308–310. (doi:10.1016/j.ijid.2020.04.044)
38. Viceconte G, Petrosillo N. 2020 COVID-19 R0: magic number or conundrum? Infect. Dis. Rep. 12, 8516. (doi:10.4081/idr.2020.8516)
39. He X et al. 2020 Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672–675. (doi:10.1038/s41591-020-0869-5)
40. Wölfel R et al. 2020 Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469. (doi:10.1038/s41586-020-2196-x)
41. Zou L et al. 2020 SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177–1179. (doi:10.1056/NEJMc2001737)
42. NHS. 2020 About coronavirus (COVID-19). See https://www.england.nhs.uk/coronavirus/ primary- care/about- covid- 19/
43. Kampf G, Todt D, Pfaender S, Steinmann E. 2020 Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 104, 246–251. (doi:10.1016/j.jhin.2020.01.022)
44. Vuorinen V. 2020 A 3D model of a person coughing in an indoor environment— how an aerosol cloud travels in the air. See https://www.youtube.com/watch?time_ continue=48&v=WZSKoNGTR6Q&feature=emb_logo.
45. Weimar B-U. 2020 Abstand halten! — Wie sich Atemluft beim Husten verbreitet. Ein Experiment der Professur Bauphysik. See https://vimeo.com/399120258.
46. Yamakawa M. 2020 Coronavirus: new facts about infection mechanisms—NHK documentary. See https://www.youtube.com/watch?v=H2azcn7MqOU.
47. Furuhashi M. 1978 A study on the microbial filtration efficiency of surgical face masks—with special reference to the non-woven fabric mask. Bull. Tokyo Med. Dent. Univ. 25, 7–15.
48. Prompetchara E, Ketloy C, Palaga T. 2020 Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 38, 1–9. See http://apjai-journal.org/wp-content/uploads/2020/02/Covid_AP-200220-0772. pdf.
49. Centers for Disease Control and Prevention. 2020 Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission. See https:// www.cdc.gov/coronavirus/2019- ncov/prevent- getting- sick/cloth- face- cover.html
50. Aydin O, Emon MAB, Saif MTA. 2020 Performance of fabrics for home-made masks against spread of respiratory infection through droplets: a quantitative mechanistic study. (https:// www.medrxiv.org/content/10.1101/2020.04.19.20071779v1)
51. Leung NHL et al. 2020 Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 26, 676–680. (doi:10.1038/s41591-020-0843-2)
royalsocietypublishing.org/journal/rspa Proc. R. Soc. A 476: 20200376 ………………………………………………….
52. World Health Organization. 2020 Coronavirus disease (COVID-19) advice for the public: when and how to use masks. See https://www.who.int/emergencies/diseases/novel- coronavirus- 2019/advice- for- public/when- and- how- to- use- masks.
53. Padron-Regalado E. 2020 Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect. Dis. Ther. 9, 1–20. (doi:10.1007/s40121-020-00300-x)
54. Nicas M, Jones RM. 2009 Relative contributions of four exposure pathways to influenza infection risk. Risk Anal. 29, 1292–1303. (doi:10.1111/j.1539-6924.2009.01253.x)
55. Eikenberry SE et al. 2020 To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect. Dis. Model. 5, 293–308.
56. Adam D. 2020 Special report: the simulations driving the world’s response to COVID-19. Nature 580, 316–318. (doi:10.1038/d41586-020-01003-6)
57. Dong E, Du H, Gardner L. 2020 An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534. (doi:10.1016/S1473-3099(20)30120-1)
58. Gibney E. 2020 Whose coronavirus strategy worked best? Scientists hunt most effective policies. Nature 581, 15–16. (doi:10.1038/d41586-020-01248-1)
59. MacIntyre CR, Seale H, Dung TC, Hien NT, Nga PT, Chughtai AA, Rahman B, Dwyer DE, Wang Q. 2015 A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 5, e006577. (doi:10.1136/bmjopen-2014-006577)
60. Watanabe T, Bartrand TA, Weir MH, Omura T, Haas CN. 2010 Development of a dose- response model for SARS coronavirus: dose-response model for SARS-CoV. Risk Anal. 30, 1129–1138. (doi:10.1111/j.1539-6924.2010.01427.x)
61. Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ. 2013 Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 9, e1003205. (doi:10.1371/journal.ppat.1003205)
62. Feng S, Shen C, Xia N, Song W, Fan M, Cowling BJ. 2020 Rational use of face masks in the COVID-19 pandemic. Lancet Respir. Med. 8, 434–436. (doi:10.1016/S2213-2600(20)30134-X).
63. Greenhalgh T, Schmid MB, Czypionka T, Bassler D, Gruer L. 2020 Face masks for the public
during the covid-19 crisis. BMJ 369, m1435. (doi:10.1136/bmj.m1435)
64. Bae S et al. 2020 Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a
controlled comparison in 4 patients. Ann. Intern. Med. (doi:10.7326/M20-1342)
65. Ong SWX et al. 2020 Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a
symptomatic patient. JAMA 323, 1610–1612. (doi:10.1001/jama.2020.3227)
66. Abaluck J et al. 2020 The case for universal cloth mask adoption and policies to increase supply of medical masks for health workers (April 1, 2020). SSRN Electron J. See https://www.ssrn.
67. Cowling BJ et al. 2020 Impact assessment of non-pharmaceutical interventions against
coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public
Health 5, e279–e288. (doi:10.1016/S2468-2667(20)30090-6)
68. Everington A. 2020 Taiwan soon to reach 13 million masks daily, N95 respirators in works.
Taiwan News, 24 March 2020. See https://www.taiwannews.com.tw/en/news/3903194.